These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11378841)

  • 1. Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis.
    Elvidge G; Jones I; McCandless F; Asherson P; Owen MJ; Craddock N
    Am J Med Genet; 2001 May; 105(4):307-11. PubMed ID: 11378841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia.
    Williams J; Spurlock G; Holmans P; Mant R; Murphy K; Jones L; Cardno A; Asherson P; Blackwood D; Muir W; Meszaros K; Aschauer H; Mallet J; Laurent C; Pekkarinen P; Seppala J; Stefanis CN; Papadimitriou GN; Macciardi F; Verga M; Pato C; Azevedo H; Crocq MA; Gurling H; Owen MJ
    Mol Psychiatry; 1998 Mar; 3(2):141-9. PubMed ID: 9577838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine D3 receptor gene: no association with bipolar affective disorder.
    Shaikh S; Ball D; Craddock N; Castle D; Hunt N; Mant R; Owen M; Collier D; Gill M
    J Med Genet; 1993 Apr; 30(4):308-9. PubMed ID: 8098068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia.
    Hawi Z; McCabe U; Straub RE; O'Neill A; Kendler KS; Walsh D; Gill M
    Mol Psychiatry; 1998 Mar; 3(2):150-5. PubMed ID: 9577839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible association between the dopamine D3 receptor gene and bipolar affective disorder.
    Parsian A; Chakraverty S; Todd RD
    Am J Med Genet; 1995 Jun; 60(3):234-7. PubMed ID: 7573178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between schizophrenia and DRD3 or HTR2 receptor gene variants.
    Baritaki S; Rizos E; Zafiropoulos A; Soufla G; Katsafouros K; Gourvas V; Spandidos DA
    Eur J Hum Genet; 2004 Jul; 12(7):535-41. PubMed ID: 15083167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders.
    Massat I; Souery D; Del-Favero J; Van Gestel S; Serretti A; Macciardi F; Smeraldi E; Kaneva R; Adolfsson R; Nylander PO; Blackwood D; Muir W; Papadimitriou GN; Dikeos D; Oruc L; Segman RH; Ivezic S; Aschauer H; Ackenheil M; Fuchshuber S; Dam H; Jakovljevic M; Peltonen L; Hilger C; Hentges F; Staner L; Milanova V; Jazin E; Lerer B; Van Broeckhoven C; Mendlewicz J
    Am J Med Genet; 2002 Mar; 114(2):177-85. PubMed ID: 11857579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of association between dopamine D3 receptor gene and bipolar affective disorder.
    Piccardi MP; Severino G; Bocchetta A; Palmas MA; Ruiu S; Del Zompo M
    Am J Med Genet; 1997 Apr; 74(2):137-9. PubMed ID: 9129711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder.
    Dikeos DG; Papadimitriou GN; Avramopoulos D; Karadima G; Daskalopoulou EG; Souery D; Mendlewicz J; Vassilopoulos D; Stefanis CN
    Psychiatr Genet; 1999 Dec; 9(4):189-95. PubMed ID: 10697826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia.
    Griffon N; Crocq MA; Pilon C; Martres MP; Mayerova A; Uyanik G; Burgert E; Duval F; Macher JP; Javoy-Agid F; Tamminga CA; Schwartz JC; Sokoloff P
    Am J Med Genet; 1996 Feb; 67(1):63-70. PubMed ID: 8678117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
    Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
    Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.
    Crocq MA; Mant R; Asherson P; Williams J; Hode Y; Mayerova A; Collier D; Lannfelt L; Sokoloff P; Schwartz JC
    J Med Genet; 1992 Dec; 29(12):858-60. PubMed ID: 1362221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians.
    Dubertret C; Gorwood P; Ades J; Feingold J; Schwartz JC; Sokoloff P
    Am J Med Genet; 1998 Jul; 81(4):318-22. PubMed ID: 9674978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients.
    Inada T; Sugita T; Dobashi I; Inagaki A; Kitao Y; Matsuda G; Kato S; Takano T; Yagi G; Asai M
    Psychiatr Genet; 1995; 5(3):113-6. PubMed ID: 8746409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
    Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
    Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association of the dopamine D3 receptor gene polymorphism (BalI) in Chinese schizophrenic males.
    Saha N; Tsoi WF; Low PS; Basair J; Tay JS
    Psychiatr Genet; 1994; 4(4):201-4. PubMed ID: 7712115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder.
    Muglia P; Jain U; Kennedy JL
    Behav Brain Res; 2002 Mar; 130(1-2):91-5. PubMed ID: 11864723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene.
    Yang L; Li T; Wiese C; Lannfelt L; Sokoloff P; Xu CT; Zeng Z; Schwartz JC; Liu X; Moises HW
    Am J Med Genet; 1993 Jul; 48(2):83-6. PubMed ID: 8103292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.